ArticleCancer immunology, immunotherapy : CII2007

Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies.

Rob C Roovers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.